Efficacy of cytokine-induced killer cell infusion as an adjuvant immunotherapy for hepatocellular carcinoma: a systematic review and meta-analysis

This study was designed to evaluate the efficacy and safety of cytokine-induced killer (CIK) cell-based immunotherapy as an adjuvant therapy for hepatocellular carcinoma (HCC). Published studies were identified by searching Medline, Cochrane, EMBASE, and Google Scholar databases with the keywords: c...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Ruili, Yang, Bo, Chi, Xiaohua, Cai, Lili, Liu, Cui, Yang, Lei, Wang, Xueyan, He, Peifeng, Lu, Xuechun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5364004/
https://www.ncbi.nlm.nih.gov/pubmed/28360510
http://dx.doi.org/10.2147/DDDT.S124399

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5364004/
https://www.ncbi.nlm.nih.gov/pubmed/28360510
http://dx.doi.org/10.2147/DDDT.S124399

Ejemplares similares